Hot Products

ONLINE INQUIRY

Human Small Intestinal Epithelial Cells

Cat.No.: CSC-C9229J

Species: Human

Source: Small Intestine; Intestine

Cell Type: Epithelial Cell

  • Specification
  • Background
  • Scientific Data
  • Publications
  • Q & A
  • Customer Review
Cat.No.
CSC-C9229J
Description
Human Small Intestinal Epithelial Cells from Creative Bioarray are isolated from normal human small intestinal tissue. Human Small Intestinal Epithelial Cells are grown in T25 tissue culture flasks pre-coated with gelatin-based coating solution for 2 min and incubated in Creative Bioarray’s Culture Complete Growth Medium generally for 3-7 days. Cultures are then expanded. Prior to shipping, cells at passage 3 are detached from flasks and immediately cryo-preserved in vials. Each vial contains at least 0.5x10^6 cells per ml. Cells can be expanded for 3-7 passages at a split ratio of 1:2 or 1:3 under the cell culture conditions specified by Creative Bioarray. Repeated freezing and thawing of cells is not recommended.
Species
Human
Source
Small Intestine; Intestine
Recommended Medium
Human Complete Epithelial Cell Medium
Cell Type
Epithelial Cell
Disease
Normal
Storage and Shipping
We ship frozen cells on dry ice. Upon receiving, directly and immediately transfer the cells from dry ice to liquid nitrogen and keep the cells in liquid nitrogen until they are needed for experiments. Never can primary cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Human small intestinal epithelial cells (IECs) are highly specialized cells that line the lumen of the small intestine, playing key roles in nutrient absorption, barrier function, and immune regulation. These cells form a monolayer epithelium organized into crypt-villus structures, which maximize the surface area for efficient nutrient uptake. Functionally, IECs are responsible for the digestion and absorption of carbohydrates, proteins, and fats by expressing specific transporters and enzymes, such as disaccharidases and peptidases. Additionally, they maintain the integrity of the intestinal barrier via tight junctions, preventing the translocation of pathogens and toxins. IECs also contribute to mucosal immunity by secreting antimicrobial peptides (e.g., defensins from Paneth cells), mucus (from goblet cells), and cytokines, while interacting with immune cells to modulate local and systemic immune responses. Some of the most severe pathological conditions, such as inflammatory bowel disease (IBD), are known to be associated with alterations of the normal growth and function of the intestinal epithelium. It is therefore of interest to investigate the physiology and pathophysiology of these cells and, not surprisingly, a large number of scientists in research fields such as intestinal physiology, intestinal immunology and cancer genesis are interested in the study of these cells.

Advantages of using human small intestinal epithelial cells include their relevance to human biology, the ability to mimic in vivo conditions, and the versatility in experimental setups. However, challenges remain, such as maintaining long-term viability and functional stability in vitro. Advances in 3D culture systems and organ-on-a-chip technologies are addressing these limitations, further enhancing their utility in biomedical research.

A cartoon depicting the cross-sectional structure of small intestine and the major cell constituents of epithelium.Fig. 1. Cross-sectional structure of small intestine and the major cell constituents of epithelium (Kong, Shanshan, et al. 2018).

Anti-Inflammatory Effects in Intestinal Epithelial Cells

Given growing understanding of the importance of peripheral inflammation, gut-health and the gut-brain axis on cognitive health, the effects of S. officinalis extract were assessed in human small intestinal epithelial cells as a model of the intestinal barrier.

Figures 1 and 2 summarize the levels of cytokines and chemokines released into apical and basolateral cell media respectively by human small intestinal epithelial cells incubated with LPS and S. officinalis extract for 24 h. Compared to the control group, the LPS treatment caused a significant increase in the release of all eight of the protein markers tested in the apical media (Fig. 1) and all but CRP and VCAM-1 in the basolateral media (Fig. 2), which supports successful induction of pro-inflammatory response by the LPS treatment.

S. officinalis extracts attenuation of cytokine and chemokine release in apical media after 24-h treatment with LPS.Fig. 1. S. officinalis extracts attenuation of cytokine and chemokine release by human small intestinal epithelial cells in apical media after 24-h treatment with LPS (Margetts, Gemma, et al. 2022).

S. officinalis extracts attenuation of cytokine and chemokine release in basolateral media after 24-h treatment with LPS.Fig. 2. S. officinalis extracts attenuation of cytokine and chemokine release by human small intestinal epithelial cells in basolateral media after 24-h treatment with LPS (Margetts, Gemma, et al. 2022).

Characterization of Conditions for The Primary Culture of Human Small Intestinal Epithelial Cells

Intestinal epithelial cells (IECs) were cultured on collagen membranes in a 12-well tissue culture cluster, with Lamina propria (LP) cells and allogeneic Epstein-Barr Virus (EBV)-transformed B lymphocytes (allo-B cells) underneath, in the well.

Primary human IECs in culture did not form confluent monolayers but cells did maintain contact with other cells in small sheets. Individual cells did maintain their cellular polarity but the cells were not all aligned on the membrane.

Initial experiments of IECs cultured above the LP fraction and allo-B cells (E/LP + B), showed that cells cultured for one day maintained their columnar/cuboid morphology and polarity (Fig. 3a, b). Morphology was further maintained when cells were cultured for 2 days (Fig. 3c, d) and for 7 days (Fig. 3f, g). All IECs expressed the human epithelial antigen as detected by Ber-EP4 antibody (Fig. 3f, g), and there was no evidence of contamination by fibroblasts.

Epithelial cells cultured over LP fraction and allo-B cells after isolation and after different lengths of culture.Fig. 3. Culture of epithelial cells above LP fraction and allo-B cells in the culture system (Aldhous, M. C., et al. 2001).

Are these cells biosafety level 1 or 2?

Our cells can be handled at biosafety level 1, but caution is always recommended when handling human tissue derived products. Hope this helps.

Ask a Question

Write your own review

For research use only. Not for any other purpose.